Literature DB >> 3756845

Metabolism of tiazofurin by human erythrocytes and mononuclear blood cells in vitro.

J D Roberts, W P Tong, J N Hartshorn, M P Hacker.   

Abstract

In vitro studies of the uptake, metabolism, and release of tiazofurin by human red blood cells reveal extensive phosphorylation with intracellular trapping of drug predominantly as tiazofurin triphosphate. This phenomenon may explain, in part, the plasma pharmacokinetic profile of tiazofurin. Metabolism of tiazofurin to tiazofurin adenine dinucleotide, the presumed oncolytic metabolite, occurs in mononuclear blood cells but not in erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756845     DOI: 10.1016/0304-3835(86)90119-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Evidence and possible consequences of the phosphorylation of nucleoside reverse transcriptase inhibitors in human red blood cells.

Authors:  Lucie Durand-Gasselin; David Da Silva; Henri Benech; Alain Pruvost; Jacques Grassi
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

2.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.